Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation (multiple letters)

Transplantation

Volumn 65, Issue 1, 1998, Pages 142-145

  Cavaille Coll, M W ^a   Elashoff, M R ^a   Pirsch, J D ^a   Miller, J ^a   Deierhoi, M H ^a   Vincenti, F ^a   Filo, R S ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

CADAVER KIDNEY; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; LIVER TRANSPLANTATION; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; CYCLOSPORINE; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GRAFT REJECTION; GRAFT SURVIVAL; HISPANIC AMERICANS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; TACROLIMUS;

EID: 0031888794     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199801150-00028     Document Type: Letter

References (0)